What is the main purpose of this 8-K filing?

The main purpose of this 8-K filing is to disclose UnitedHealth Group's updated 2023 financial outlook and to provide initial financial projections for 2024, as detailed in an accompanying press release.

When can investors expect more detailed financial information?

Investors can expect more detailed financial information and discussion during the webcast and management Q&A session scheduled for November 29, 2023, starting at 8:00 a.m. ET. Conference materials will be available on the company's Investor Relations website from 6:30 a.m. ET on the same day.

Where can I find the press release mentioned in the filing?

The press release dated November 28, 2023, is attached as Exhibit 99.1 to this 8-K filing and is incorporated by reference. It can also likely be found on the UnitedHealth Group Investor Relations website.

Does this filing contain specific financial numbers or guidance?

This 8-K filing itself does not contain the specific financial numbers or guidance. It serves as a notification that a press release with that information has been issued, and that information is incorporated by reference. Investors should refer to the press release (Exhibit 99.1) and the subsequent webcast for the detailed financial outlook and projections.

UNH 8-K: Regulation FD — Nov 28, 2023

Summary

UnitedHealth Group (UNH) has filed an 8-K report on November 28, 2023, announcing an update to its 2023 financial outlook and providing initial projections for 2024. This filing primarily references a press release issued on the same date, which contains the key forward-looking financial information that investors will be keen to review. The company also indicated that it would be hosting a webcast and Q&A session on November 29, 2023, to discuss these projections further and provide accompanying materials.

Key Highlights

1UNH issued a press release on November 28, 2023, providing an updated 2023 financial outlook.
2Initial financial projections for the fiscal year 2024 were also released.
3A webcast and management Q&A session is scheduled for November 29, 2023, at 8:00 a.m. ET.
4Conference materials will be available on the Company's Investor Relations website starting at 6:30 a.m. ET on November 29, 2023.
5The press release (Exhibit 99.1) is incorporated by reference into the 8-K filing.
6The information furnished under Item 7.01 is generally not considered 'filed' for certain SEC regulations unless expressly incorporated by reference in other filings.

UNITEDHEALTH GROUP INC 8-K Report, Regulation FD Disclosure (Nov 28, 2023)

Summary

Key Highlights

Frequently Asked Questions